Drug Development Crisis Linked To Bad Technology Choices
Science Related News
Despite lower costs and increased speed of research inputs, the budget for getting a drug to market is soaring. Researchers suggest that a focus on process efficiency has favoured experimental models with less validity, more than outweighing efficency benefits.
Source